McKesson Corp (MCK) — Q1 FY27 Earnings Call Live coverage with Benzinga. Q1 FY27 Results EPS: $9.93 (est. $9.62) — inline Revenue: $105.38B (est. $104.08B) — inline Reported: 2026-08-05 Recent Quarters Q4 FY26 (2026-05-07): EPS $11.69 vs est $11.57 · Rev $96.30B vs est $101.49B Q3 FY26 (2026-02-04): EPS $9.34 vs est $9.29 · Rev $106.16B vs est $105.81B Q2 FY26 (2025-11-05): EPS $9.86 vs est $9.00 · Rev $103.15B vs est $104.34B Q1 FY26 (2025-08-06): EPS $8.26 vs est $8.18 · Rev $97.83B vs est $96.23B About McKesson Corp McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution i...